EyePoint Pharmaceuticals, Inc. (44) | Share Agreements (2)
- First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on February 3, 2021)
- Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics (Filed With SEC on January 4, 2021)
